SV2 PET Imaging With [11C]APP311
Recruiting · NCT03995121 · Observational (researchers observe without assigning treatment) · Lead sponsor: Yale University
View the official record on ClinicalTrials.gov →Interventions studied
[11C]APP311
What this trial is about
The aim of this study is to evaluate a new SV2A tracer, \[11C\]APP311, in healthy aging and neuropsychiatric disorders including psychotic disorders and cannabis use disorders.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Willing and able to give voluntary written informed consent
- Male and Female subjects, age 18 to 65 years, inclusive
Exclusion criteria
- MRI metal exclusions and claustrophobia.
- Education completed is less than 12 years
Where it is running
1 location listed across 1 US state.
- Conneticut Mental Health Center - New Haven, Connecticut, United States